|
|
|
|
LEADER |
02026nam a2200301 u 4500 |
001 |
EB001897151 |
003 |
EBX01000000000000001060156 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
200523 r ||| eng |
100 |
1 |
|
|a Brett, Kendra
|
245 |
0 |
0 |
|a Sugammadex for the reversal of rocuronium-induced neuromuscular blockade in surgical patients
|h Elektronische Ressource
|b a review of clinical effectiveness
|c Kendra Brett, Kelly Farrah
|
246 |
3 |
1 |
|a Summary with critical appraisal sugammadex for the reversal of neuromuscular blockade in surgical patients
|
260 |
|
|
|a Ottawa (ON)
|b Canadian Agency for Drugs and Technologies in Health
|c August 21, 2019, 2019
|
300 |
|
|
|a 1 PDF file (39 pages)
|b illustrations
|
505 |
0 |
|
|a Includes bibliographical references
|
653 |
|
|
|a Sugammadex
|
653 |
|
|
|a Anesthesia Recovery Period
|
653 |
|
|
|a Treatment Outcome
|
653 |
|
|
|a Rocuronium / antagonists & inhibitors
|
700 |
1 |
|
|a Farrah, Kelly
|e [author]
|
710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
490 |
0 |
|
|a CADTH rapid response report: summary with critical appraisal
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK549465
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
082 |
0 |
|
|a 610
|
520 |
|
|
|a In patients undergoing surgery requiring general anesthesia, a neuromuscular blocking agent is often used to paralyze the vocal cords and facilitate intubation of the trachea and improve surgical conditions. At the conclusion of surgery, the NMB must be reversed, and depending on the depth of the NMB, the recovery may be spontaneous or a reversal agent can be administered. The purpose of this report is to synthesize and critically appraise the available evidence on the clinical effectiveness of sugammadex for rocuronium-induced NMB in patients undergoing surgery. This information may be used to inform decision making relating to health policy of the use of sugammadex
|